REGN 241206 735.00P (REGN241206P735000) Stock Options, News & Quotes

US OptionsDetailed Quotes

REGN241206P735000

Watchlist

2.25
+0.05+2.27%

15min DelayTrading Dec 3 10:17 ET

2.25High2.25Low

Intraday

5D
Daily

News

Tuesday S&P 500 Pulls Back From Highs, Nasdaq Climbs | Live Stock
Kevin TraversDec 3 10:27 ET
Regeneron Pharmaceuticals (NASDAQ:REGN) Shareholders Have Earned a 16% CAGR Over the Last Five Years
Simply Wall StDec 3 09:24 ET
Maia Biotechnology, Regeneron Expand Clinical Supply Deal
MT NewswiresDec 3 09:19 ET
Express News | Maia Biotechnology Inc - Expects New Patient Enrollment to Begin Soon
ReutersDec 3 08:17 ET
Express News | Maia Biotechnology Inc - Expansion of 2021 Clinical Supply Agreement for Phase 2 Trial
ReutersDec 3 08:17 ET
Medigene Receives Milestone Payment From Regeneron Pharmaceuticals, Inc.
Yahoo FinanceDec 3 05:00 ET

Comments

韭菜变主力

Nov 25 09:31

$Regeneron Pharmaceuticals (REGN.US)$ Bought at 743, see how it goes.

NathanRobert

Nov 13 15:03

5 Quality Stocks That Are Undervalued

🔥 We go over 5 stocks that look undervalued, i show you the numbers for yourself, i own 1 of the stocks on the list, but i try to go over stocks you’ve probably never heard of before! LMK ur thoughts :)
$Hershey (HSY.US)$ $Celsius Holdings (CELH.US)$ $Regeneron Pharmaceuticals (REGN.US)$ $Yelp Inc (YELP.US)$ $Innovative Industrial Properties Inc (IIPR.US)$

https://youtu.be/4qd-58cBqi4

From YouTube

10xStockPicks

Oct 24 07:55

Hugely Undervalued $2 Biotech With 21% Held Short $16 Price Target, Takeover Candidate, Soon Profitable

Esperion $Esperion Therapeutics (ESPR.US)$ We reiterate Strong Buy rating. Esperion has the only FDA approved statin alternative drugs NEXLIZET & NEXLETOL for Primary Prevention, an estimated 21 Million Americans are Statin intolerant and or maxed out on Statin drugs and need additional lowering. Over 71 million Americans take statin drugs, we see continued prescription growth & expect over 5...

+20

Meltyy

Sep 25 06:31

See FDA PDUFA update 👀 👇

🚨 This Week’s PDUFAs:
$Heron Therapeutics (HRTX.US)$ : 🤔
⇨ ZYNRELEF® Vial Access Needle
‣ Postoperative pain
‣ PDUFA: 9/23/24 (sNDA)
$Bristol-Myers Squibb (BMY.US)$ : 🤔
⇨ KarXT (xanomeline-trospium)
‣ Schizophrenia
‣ PDUFA: 9/26/24 (NDA)
$Sanofi (SNY.US)$ $Regeneron Pharmaceuticals (REGN.US)$ : 🤔
⇨ Dupixent
‣ Chronic obstructive pulmonary disease
‣ PDUFA: 9/27/24 (sBLA)
$BeiGene (BGNE.US)$ $Merck & Co (MRK.US)$ & $Bristol-Myers Squibb (BMY.US)$ : 🤔
⇨ Tislelizumab, KEYTRUDA, OPDIVO & YER...